157284-85-0

Basic information

• Product Name: methyl 2-(4-hydroxybenzyl)-3-oxobutanoate
• Synonyms: methyl 2-(4-hydroxybenzyl)-3-oxobutanoate
• CAS NO: 157284-85-0
• Molecular Weight: 222.241
• Mol File: 157284-85-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 2-(4-hydroxybenzyl)-3-oxobutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-hydroxybenzyl)-3-oxobutanoate(157284-85-0)
• EPA Substance Registry System: methyl 2-(4-hydroxybenzyl)-3-oxobutanoate(157284-85-0)

Safety Data

• Hazardous Substances Data: 157284-85-0(Hazardous Substances Data)

Upstream product

• 761379-74-2 methyl 2-(4-hydroxybenzylidene)-3-oxobutanoate 
• 106521-81-7 methyl 2-(4-methoxy benzylidene)-3-oxobutanoate 
• 123-11-5 4-methoxy-benzaldehyde 
• 105-45-3 acetoacetic acid methyl ester 
• 123-08-0 4-hydroxy-benzaldehyde 
• 157284-83-8 2-acetyl-3-(4-hydroxy-phenyl)-acrylic acid methyl ester 

Downstream Products

• 851180-88-6 3-methyloxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester 
• 851181-36-7 3-cyclopropylmethoxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester 
• 851180-90-0 3-benzyloxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester 
• 851180-98-8 2-(4-hydroxy-benzyl)-2-methyl-3-oxo-butyric acid methyl ester 
• 932025-01-9 3-(4-fluoro-benzyloxyimino)-2-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-butyric acid methyl ester 
• 932025-08-6 3-(2-fluoro-ethoxyimino)-2-(4-{2-[2-(4-fluoro-phenyl)-5-methyl-oxazol-4-yl]-ethoxy}-benzyl)-butyric acid methyl ester 

Relevant articles and documents

Design, synthesis and computational validation of novel benzimidazole/indole-based PPARα and PPAR? partial agonists

The design and synthesis of benzimidazolyl and indolyl linked α-alkoxy phenylpropanoic acid derivatives and the β-keto ester analogues in an effort to develop novel peroxisome proliferator activated receptors ligands expected to exhibit PPARα and PPAR? pa

NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.